1-158717700-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001005327.3(OR6K3):c.416G>A(p.Arg139Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000205 in 1,461,626 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R139W) has been classified as Uncertain significance.
Frequency
Consequence
NM_001005327.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR6K3 | NM_001005327.3 | c.416G>A | p.Arg139Gln | missense_variant | 2/2 | ENST00000368145.2 | NP_001005327.2 | |
OR6K3 | XM_047420296.1 | c.416G>A | p.Arg139Gln | missense_variant | 3/3 | XP_047276252.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR6K3 | ENST00000368145.2 | c.416G>A | p.Arg139Gln | missense_variant | 2/2 | 6 | NM_001005327.3 | ENSP00000357127.1 | ||
OR6K3 | ENST00000368146.1 | c.464G>A | p.Arg155Gln | missense_variant | 1/1 | 6 | ENSP00000357128.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250660Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135440
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461626Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727122
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 20, 2021 | The c.416G>A (p.R139Q) alteration is located in exon 1 (coding exon 1) of the OR6K3 gene. This alteration results from a G to A substitution at nucleotide position 416, causing the arginine (R) at amino acid position 139 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at